Operating Segments (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Summary of segmental information
Revenues	$ 4,629,916	$ 5,241,448
Income (Loss) from Operations	(10,541,021)	(9,058,981)
Amortization and Depreciation Expense	54,450	44,060
Other Income, Net	574,753	159,006
Share-Based Compensation	376,339	380,886
Identifiable Assets	7,775,360	10,491,702
Public Health Solutions [Member]
Summary of segmental information
Revenues	3,402,014	4,156,641
Income (Loss) from Operations	153,969	(237,640)
Amortization and Depreciation Expense	17,507	17,951
Share-Based Compensation	36,003	57,307
Identifiable Assets	1,018,673	1,181,114
Specialized BioTherapeutics [Member]
Summary of segmental information
Revenues	1,227,902	1,084,807
Income (Loss) from Operations	(6,738,284)	(5,439,294)
Amortization and Depreciation Expense	18,122	21,018
Other Income, Net	425,785
Share-Based Compensation	107,214	117,570
Identifiable Assets	41,705	78,336
Corporate [Member]
Summary of segmental information
Income (Loss) from Operations	(3,956,706)	(3,382,047)
Amortization and Depreciation Expense	18,821	5,091
Other Income, Net	148,968	159,006
Share-Based Compensation	233,122	206,009
Identifiable Assets	$ 6,714,983	$ 9,232,252